Leap Therapeutics, Inc. (LPTX) (LPTX) reported Loss for first quarter that beat the Street estimates.
The company's bottom line totaled -$15.44 million, or -$0.37 per share. This compares with -$13.82 million, or -$0.51 per share, last year.
Analysts on average had expected the company to earn -$0.38 per share. Analysts' estimates typically exclude special items.
Leap Therapeutics, Inc. (LPTX) earnings at a glance (GAAP) :
-Earnings: -$15.44 Mln. vs. -$13.82 Mln. last year.
-EPS: -$0.37 vs. -$0.51 last year.
For comments and feedback: editorial@rttnews.com